Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Collagenase-2** (also known as collagenase type 2) is a purified protein enzyme preparation isolated from *Clostridium histolyticum*, prepared to contain higher clostripain activity compared to other collagenase types[3][7]. It is mainly used for the isolation of primary cells from tissues such as bone, heart, liver, thyroid, and salivary gland, due to its proteolytic action on collagen and extracellular matrix proteins[3][7]. Its main clinical application is in research and laboratory contexts for tissue dissociation and cell isolation, rather than as a direct pharmaceutical for human therapy. It hydrolyzes collagen by cleaving the collagen triple helix and is distinguished from other collagenases by specific enzyme composition and tissue suitability[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagenase-2.